Press Statement Issued by Ranbaxy Laboratories Limited
GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy
has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP". Ranbaxy
Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
Toronto Stock Exchange Symbol: DND
MISSISSAUGA, ON, Aug. 6 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals
Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has
entered into a definitive development, distribution and supply agreement
Pharmaceuticals Inc. ("RPI"...
Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
Zenotech Laboratories Ltd today said it will issue 20 lakh equity shares to Ranbaxy
Laboratories on a preferential basis for Rs 20 crore. //
The board of directors has approved the issue of 20 lakh equity shares of Rs 10 at a price of Rs 100 on a preferential basis to Ranbaxy, subject to shar...
Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
New Delhi: SRL Ranbaxy
has introduced a diagnostic test for Bird Flu that will enable mass-screening, and has the capability to report near accurate results within 24 hours. Named as RT-PCR test, // this test boasts of being powerful where the results will be available in a day. Certainly a blessin...
SRL Ranbaxy offers quicker bird flu diagnostic test
SRL Ranbaxy, a pathology laboratory network promoted by India's pharma major Ranbaxy
Laboratories, Monday announced the launch of the first diagnostic// test for bird flu that can give results in just a day.
"A first of its kind, it is the only diagnostic test for bird flu that can be effectivel...
Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA Ranbaxy
Laboratories (RL) has received its first tentative approval from the US Food and drug administration ( FDA ) to manufacture // and market lamivudine tablets that can be used in combination with other anti - retroviral agents (ARVs) to treat patients with HIV infection.
The approval ha...
New FDLI Book Maps Out Pharmacovigilance Provisions in More Than a Dozen Countries
...arthritis. The contaminated heparin caused dozens of deaths and hundreds of injuries.
In February 2009, the Food and Drug Administration accused ranbaxy
Pharmaceuticals, an Indian manufacturer of generic drugs, of falsifying data used to obtain regulatory approval for U.S. distribution.
Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
... PRINCETON, N.J., March 5 /PRNewswire/ -- ranbaxy
Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of ranbaxy
Laboratories Limited (RLL), announced today that R.... Food and Drug Administration, has determined the ranbaxy
formulations to be bioequivalent and have the same...
FDA Halts New Applications From Indian Drug Maker's Plant
... Agency says ranbaxy
Laboratories facility falsified scientific data
...ted the review of any new drug applications from a ranbaxy
Laboratories plant in India after determining the ... Sahib facility in less than six months. "No other ranbaxy
facilities are directly affected by this action," ...
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
Will Market Generic Atorvastatin in the U.S. With ... $12.7 billion.
The agreement pertains solely to ranbaxy
and its affiliates and does
not cover legal challe...involving other generic
manufacturers. However, as ranbaxy
was the first generic challenger to the
RANBAXY in Medical Technology
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding
...y signed license agreements for the sales and
marketing of Sanvar(R), with several commercial partners that include Salix
Pharmaceuticals in the U.S., ranbaxy
Laboratories Ltd in India, EMS Sigma
Farma in Brasil, LG Life Sciences in Korea, Tzamal Bio-Pharma Ltd in
Israel, and Medical Futures in Canada.
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
... PRINCETON, N.J., Aug. 20 /PRNewswire/ -- ranbaxy
(RPI), a wholly owned subsidiary of ranbaxy
Laboratories Limited (RLL),
announced today that R.... Food and Drug
Administration, has determined the ranbaxy
formulations to be bioequivalent
and have the same...
RANBAXY in Biological News
SCI marks expansion into Asia with the launch of SCI INDIA
...ju Shroff, Chairman & Managing Director of United Phosphorus Limited, Dr. Ian Cliffe, Director-Head, Medicinal Chemistry, New Drug Discovery Research, ranbaxy
Laboratories Limited, Mr. Raj Kapur, Regional Manager South Asia, Managing Director India, Dow Corning India Pvt. Ltd, Mr . Pradip Dave, Chairman & ...
RANBAXY in Biological Technology
Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation
TOKYO, and NEW DELHI, India, July 17 /PRNewswire/ -- Following intense
speculation in sections of the media and the stock market, Daiichi Sankyo
Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo") and Ranbaxy
Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy") reiterate that the agreemen...
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
TOKYO and RIDGEFIELD, Conn., Nov. 8 /PRNewswire/ -- Astellas Pharma
Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. (a subsidiary of
Boehringer Ingelheim Corporation) announced today that the two companies
have reached a settlement agreement with Ranbaxy
to enter into a
stipulation of dism...
Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules in the U.S.
... PRINCETON, N.J., May 1 /PRNewswire/ -- ranbaxy
Pharmaceuticals Inc. (RPI) announced today that it...rmity with the approved laboratory specifications, ranbaxy
decided to recall all the lots, as a matter of abu... commitment to the health and safety of patients. ranbaxy
is continuing to look into the cause of such non-c...
Ranbaxy Launches Omeprazole 40 mg Capsules
...s of trade in the U.S. healthcare system under the ranbaxy
said Jim Meehan, Vice President of Sales a...mulation to
patients requiring this medication."
Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a
wholly owned subsidiary of ranbaxy
Laboratories Limited (RLL), India's
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets
PRINCETON, N.J., June 25 /PRNewswire/ -- ranbaxy
(RLL), announced today that t...blets were $239 million (IMS - MAT: March 2008).
believes that it has First-to-File status on Valga...alue and utility over time. It will be launched by ranbaxy
receiving final approval and resolution of li...
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
... key member of the
team that established collaboration agreements between Merck and leading
pharmaceutical firms in India such as Nicholas Piramal and ranbaxy
Dr. Chowrira also served as Vice President of Sirna Therapeutics, a wholly
owned subsidiary of Merck, where his responsibilities included strate...
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
...prazole magnesium. Under the settlement agreement, ranbaxy
that all six patents asserted by AstraZen...enforceable.
The settlement agreement will allow ranbaxy
to commence exclusive sales
of a generic version o...Esomeprazole magnesium product in the US market.
has filed a Consent Judgment with the U.S. Distric...
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
... PRINCETON, N.J., Feb. 7 /PRNewswire/ -- ranbaxy
(RPI), a wholly owned subsidiary of ranbaxy
Laboratories Limited (RLL),
announced today that R...les of
$5.5 billion (IMS -- MAT: December 2007).
believes that it has a FTF (First to File) status ...
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
...(R) product. The defendants
named in the lawsuit include Dr. Reddy's Laboratories Limited, Genpharm
Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., ranbaxy
Limited, Sun India Pharmaceutical Industries Limited, and related companies
and subsidiaries thereof. The '703 patent expires in April 20...
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
...es to 45%
GURGAON, India, Oct. 3 /PRNewswire/ -- ranbaxy
(Ranbaxy) and Zenotech Labora...ents, providing for an increase in equity stake
from its current 7% to 45% at a price of Rs. 160 p... the existing Promoters (b) Preferential Offer to ranbaxy
by Zenotech The above triggers a mandatory open o...